Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.caplinpoint.net | |
Market Cap | 5,203.17 Cr. | |
Enterprise Value(EV) | 4,706.36 Cr. | 2022-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 43.57 | Trailing Twelve Months Ending 2022-09 |
Price-Earning Ratio (PE) | 15.78 | Trailing Twelve Months Ending 2022-09 |
Industry PE | 32.90 | Trailing Twelve Months Ending 2022-09 |
Book Value / Share | 222.11 | Trailing Twelve Months Ending 2022-09 |
Price to Book Value | 3.10 | Calculated using Price: 687.50 |
Dividend Yield | 0.58 | Period Ending 2022-03 |
No. of Shares Subscribed | 7.59 Cr. | 75,897,746 Shares |
FaceValue | 2 | |
Company Profile | ||
Caplin Point is the mid-sized company in India's pharmaceutical sector to be engaged in the manufacture of APIs, finished formulations, research & development, clinical research, frontend generic presence in Latin America, brand marketing in Francophone Africa and an USFDA approved injectable facility. |
1 Day |
|
-0.11% |
1 Week |
|
-1.24% |
1 Month |
|
-3.77% |
3 Month |
|
-8.10% |
6 Month |
|
-9.14% |
1 Year |
|
-15.13% |
2 Year |
|
+47.42% |
5 Year |
|
+6.19% |
10 Year |
|
+3999.58% |
9 years | 2014-06 | 2015-06 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
Return on Equity (%) | 53.24 | 55.78 | 43.13 | 54.97 | 49.43 | 37.14 | 29.58 | 25.65 | 24.71 | |
Return on Capital Employed (%) | 68.99 | 71.11 | 55.41 | 69.03 | 64.08 | 45.59 | 33.35 | 28.82 | 28.77 | |
Return on Assets (%) | 16.48 | 20.12 | 18.46 | 30.54 | 33.68 | 28.41 | 23.02 | 20.20 | 19.94 |
Particulars | 10 years | 2014-06 Rs. Cr. | 2015-06 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09* Rs. Cr. |
Shh. Funds | 62 | 93 | 128 | 225 | 364 | 633 | 948 | 1,186 | 1,484 | 1,686 | |
Non Curr. Liab. | 10 | 10 | 14 | 20 | 28 | 23 | 25 | 17 | 13 | 5 | |
Curr. Liab. | 108 | 125 | 125 | 113 | 109 | 86 | 144 | 143 | 208 | 294 | |
Minority Int. | 0 | 0 | 0 | 0 | 0 | 0 | 9 | 18 | 26 | 28 | |
Equity & Liab. | 180 | 229 | 267 | 358 | 500 | 743 | 1,126 | 1,364 | 1,730 | 2,012 | |
Non Curr. Assets | 131 | 147 | 149 | 179 | 196 | 249 | 303 | 349 | 432 | 468 | |
Curr. Assets | 49 | 82 | 119 | 179 | 304 | 494 | 823 | 1,015 | 1,298 | 1,544 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 180 | 229 | 267 | 358 | 500 | 743 | 1,126 | 1,364 | 1,730 | 2,012 |
Particulars | 10 years | 2014-06 Rs. Cr. | 2015-06 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09 Rs. Cr. TTM |
Net Sales | 173 | 252 | 239 | 402 | 540 | 649 | 863 | 1,061 | 1,269 | 1,371 | |
Other Income | 4 | 3 | 4 | 10 | 13 | 19 | 41 | 28 | 39 | 51 | |
Total Income | 177 | 255 | 242 | 412 | 553 | 668 | 905 | 1,089 | 1,308 | 1,422 | |
Total Expenditure | -137 | -192 | -175 | -277 | -345 | -417 | -603 | -737 | -875 | -962 | |
PBIDT | 40 | 63 | 68 | 135 | 208 | 251 | 301 | 352 | 433 | 460 | |
Interest | -1 | -1 | 0 | -1 | -1 | -1 | 0 | -2 | -1 | 0 | |
Depreciation | -4 | -8 | -7 | -13 | -19 | -23 | -32 | -37 | -47 | -46 | |
Taxation | -10 | -12 | -14 | -25 | -44 | -50 | -54 | -62 | -77 | -76 | |
Exceptional Items | |||||||||||
PAT | 26 | 41 | 46 | 96 | 145 | 177 | 215 | 251 | 308 | 338 | |
Minority Interest | 0 | 0 | 0 | 0 | 0 | -9 | -9 | -8 | |||
Share Associate | 0 | ||||||||||
Other Related Items | |||||||||||
Consolidated Net Profit | 26 | 41 | 46 | 96 | 145 | 177 | 215 | 242 | 300 | 331 | |
Adjusted EPS | 3 | 5 | 6 | 13 | 19 | 23 | 28 | 32 | 40 | 44 |
Particulars | 10 years | 2013-06 Rs. Cr. | 2014-06 Rs. Cr. | 2015-06 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
Cash Fr. Operatn. | 32 | 60 | 50 | 42 | 68 | 66 | 83 | 45 | 269 | 337 | |
Cash Fr. Inv. | -45 | -44 | -23 | -6 | -36 | -69 | -100 | -55 | -29 | -271 | |
Cash Fr. Finan. | -1 | -6 | -9 | -14 | -7 | -12 | 90 | 80 | -24 | -41 | |
Net Change | -15 | 10 | 19 | 23 | 25 | -14 | 73 | 70 | 215 | 25 | |
Cash & Cash Eqvt | 17 | 27 | 45 | 68 | 91 | 77 | 151 | 221 | 436 | 461 |
Thu, 12 Jan 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Share certificates has been reported as lost by the shareholders of the Company. |
Thu, 05 Jan 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate This is to inform that below mentioned share certificates has been reported as lost by the shareholders of the Company. |
Wed, 04 Jan 2023
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 Intimation pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 |
Fri, 27 Jan 2023 |
|
|
|
|
|